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ABSTRACT
DNA methylation is a key regulatory control route in
epigenetics, involving gene silencing and chromo-
some inactivation. It has been recognized that
methyl-CpG binding domain (MBD) proteins play
an important role in interpreting the genetic infor-
mation encoded by methylated DNA (mDNA).
Although the function of MBD proteins has attracted
considerable attention and is well characterized,
the mechanism underlying mDNA recognition by
MBD proteins is still poorly understood. In this
article, we demonstrate that the methyl-CpG
dinucleotides are recognized at the MBD–mDNA
interface by two MBD arginines through an interplay
of hydrogen bonding and cation-n interaction.
Through molecular dynamics and quantum-
chemistry calculations we investigate the methyl-
cytosine recognition process and demonstrate that
methylation enhances MBD–mDNA binding by
increasing the hydrophobic interfacial area and by
strengthening the interaction between mDNA and
MBD proteins. Free-energy perturbation calcula-
tions also show that methylation yields favorable
contribution to the binding free energy for MBD–
mDNA complex.
INTRODUCTION
DNA methylation is an epigenetic modiﬁcation of eukary-
otic genomes, including plant genomes, involving the
addition of a methyl group at the 5-position of cytosine
in CG dinucleotides (1–4). It is now well established
that DNA methylation plays an essential role in organ-
ismal development, e.g. controlling gene expression,
X-chromosome inactivation and gene imprinting (5,6).
In the cell, DNA methylation exerts its biological
function in at least two ways. First, DNA methylation
affects promoter regions to impede binding of transcrip-
tional factors to the gene and, hence, directly interferes
with gene activation (7–9). Second, DNA methylation
attracts proteins that bind to the methyl-CpG (mCpG)
steps and leads to the formation of silenced states of chro-
matin, which inﬂuence gene activity (10–15). A family of
proteins that recognize mCpG steps in DNA, known as
methyl-CpG binding domain (MBD) proteins, recruit
co-repressor complexes that alter chromatin structure,
thereby repressing transcription from non-methylated
CpG promoters (16–19).
Biological functions of the MBD proteins in epigenetic
regulation have been studied over several decades. At
present, ﬁve proteins with mCpG-binding motifs have
been identiﬁed in the MBD family, namely MBD1
(20,21), MBD2 (22,23), MBD3 (24), MBD4 (25) and
MeCP2 (26–28). In mammals, MBD1, MBD2 and
MeCP2 have been observed to bind to mCpG steps and
to repress gene transcription. MBD4 binds to T:G
mismatches caused by deamination of the methylated
cytosine at mCpG sites and is involved in DNA repair
(29). Mammalian MBD3 does not bind to the methylated
DNA (mDNA) due to the lack of several important amino
acids that are conserved in other MBD proteins (16).
All MBD proteins share a similar MBD of about 75
amino acid residues. Sequence alignment of MBD
proteins reveals several highly conserved residues on the
interface between MBD and methylated DNA (mDNA).
Figure 1 shows that the most conserved region in the
primary structure of the MBD is located between
residues ARG22 and LYS46, including loop L1, strand
b3, strand b4 and loop L2. The conserved residues of
the MBD form the interfacial surface contacting mDNA
and are responsible for recognition of the methyl-CpG
steps.
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structure of MeCP2 proteins bound to the mDNA provide
useful information on how residues in the MBD contact
mDNA (21,23,28). Figure 2 illustrates the MBD inter-
action with the mCpG steps in the major groove of
mDNA. The methyl groups of methyl-cytosine are
buried in the mDNA–MBD interface. The principal
mCpG binding interface composed of hydrophilic and
hydrophobic residues involves two types of interaction
with mCpG steps (30): the polar atoms in MBD form
hydrogen bonds with the polar atoms in the DNA, while
the non-polar atoms in MBD form a hydrophobic patch
around the methyl groups. However, a detailed picture of
how the MBD recognizes mCpG steps over CpG steps,
e.g. the inﬂuence of methyl groups on the thermodynamics
of MBD–DNA binding, is still poorly characterized.
Binding of a protein to a speciﬁc DNA sequence
involves complex binding networks of electrostatic and
hydrophobic interactions. Earlier investigations suggested
that the pyrimidine-guanine dinucleotide step is
recognized by an interaction network in which an
arginine is featured prominently through a coupled
hydrogen bonding/cation-p interaction (31–34). The con-
formation composed of pyrimidine, guanine and arginine
is usually referred to as the PYR ; ARG _ GUA stair
motif (; denotes the cation-p interaction and _ denotes
the hydrogen bonding), which includes three interactions:
nucleobase stacking (arising between pyrimidine and
guanine), hydrogen bonding (arising between guanine
and arginine) and cation-p interaction (arising between
pyrimidine and arginine) (35,36). The stair motif was
observed in the structure of MBD2–mDNA and
MeCP2–mDNA complexes, in which the arginine amino
acids form hydrogen bonds with the guanine bases and
concomitantly stack with the methyl-cytosines (23,28).
Since the two arginines involved in the stair motifs are
conserved in all MBD proteins (see Figure 1), it is likely
that recognition of the mCpG dinucleotide by MBD
proteins is mediated by stair motifs which are stabilized
through methyl groups. Although previous studies have
reported the two arginine forming hydrogen bonds with
the guanines, the stacking interaction between the
methyl-cytosines and the arginines has always been
neglected.
In the present study, we performed molecular dynamics
(MD) simulations (37) of the MBD1–DNA, MBD2–DNA
and MeCP2–DNA complexes in order to reveal the
general mechanism whereby the MBD recognizes the
mCpG steps. The simulations demonstrate formation of
the stable stair motif at the MBD–mDNA binding inter-
face. Comparison between MBD–nDNA (nDNA denotes
non-methylated DNA) and MBD–mDNA interactions
shows that DNA methylation stabilizes the stair motif,
thereby facilitating mCpG recognition by the MBD. The
strong effect of methylation on reducing the solvent ac-
cessible surface at the MBD–mDNA interface is observed
through calculation of the contact area between
MBD protein and DNA. Quantum-chemistry analysis
Figure 1. Sequence alignment of ﬁve methyl-CpG binding domain (MBD) proteins from human and mouse. A red-white-blue color scale is used to
indicate sequence similarity. The most conserved residues are shown in dark blue, while the less conserved residues are indicated in red.
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on the stability of the MBD–mDNA complex. Free-
energy perturbation (FEP) calculations determine the
overall methylation-induced free-energy change in
MBD–mDNA binding. Finally, MD simulations on
mutants of MBD1 bound with mDNA reveal the import-
ant role of other residues in MBD–mDNA binding.
METHODS
We performed molecular dynamics simulations for three
crystal structures, namely MBD1–mDNA, MBD2–
mDNA and MeCP2–mDNA, to examine the mechanism
of methyl-CpG recognition by the MBD of the MBD
protein family. To characterize the role of the methyl
groups in MBD–mDNA binding, we compared the
thermodynamics of the binding surface of MBD1–
mCpG and MBD1–CpG steps. Five mutants of MBD1
binding with methylated DNA were simulated to charac-
terize the involvement of speciﬁc side groups in
recognizing mCpG steps. Ab initio quantum-chemistry
calculations were employed to account in electronic
detail for the inﬂuence of methylation on enhancing the
interaction between MBD and DNA.
Molecular dynamics simulations
Atomic models. Nine molecular complexes were studied in
this work: (i) wild-type MBD1–mDNA, (ii) mutant
MBD1–nDNA, (iii) mutant V20A MBD1–mDNA, (iv)
mutant R22A MBD1–mDNA, (v) mutant Y34A
MBD1–mDNA, (vi) mutant R44A MBD1–mDNA, (vii)
mutant S45A MBD1–mDNA, (viii) wild-type MBD2–
mDNA and (ix) wild-type MeCP2–mDNA (see Table 1).
Atomic coordinates of wild-type MBD1–mDNA, see (i),
were taken from the well-deﬁned protein residues 3–69 in
the NMR structure of the MBD of human MBD1 com-
plexed with mDNA (Protein Data Bank entry code 1IG4)
(21). The mutant structure for MBD1–nDNA, see (ii), was
obtained by mutating the methylated cytosines to
non-methylated ones. Five mutated structures of the
MBD1–mDNA complex, see (iii)–(vii), were obtained by
mutating the residues of interest in the wild-type complex
using the MUTATOR plug-in in VMD (38). The
MUTATOR plug-in removes the structural information
of a given residue and generates new coordinates for the
desired mutant amino acid based on the internal coordin-
ates provided in standard CHARMM topology ﬁles. The
atomic coordinates of wild-type MBD2–mDNA, see (viii),
and MeCP2–mDNA, see (ix), were taken from the NMR
structure of chicken MBD2 bound to mDNA (Protein
Data Bank entry code 2KY8) (23) and the X-ray structure
of human MeCP2 bound to mDNA (Protein Data Bank
entry code 3C2I) (28), respectively.
The topology ﬁle of DNA and protein along with the
missing hydrogen atoms was generated using the psfgen
plug-in of VMD (39). Each complex was placed in a water
box with 0.1mol/l KCl added. The total size of the
simulated systems lies in the 50000–60000 atom range.
Molecular dynamics. Simulations were performed using
the program NAMD 2.7 with the CHARMM27 force
ﬁeld for DNA (40), the CHARMM22 force ﬁeld for
proteins with CMAP corrections (41,42) and the TIP3P
water model (43). The parameters for 5-methylcytosine are
available in the CHARMM27 force ﬁeld (40). Periodic
boundary conditions were assumed and the particle-mesh
Ewald (PME) summation method was employed for
evaluating Coulomb forces. The van der Waals (vdW)
energy was calculated using a smooth cutoff of 12 A ˚ .
Figure 2. MBD proteins binding to mDNA. Shown are the structures of (a) MBD1-mDNA, (b) MBD2-mDNA and (c) MeCP2–mDNA complexes.
The methyl-cytosines are indicated in red. The DNA sequence for each complex is shown below the corresponding image. The stair motif mCYT ;
ARG m GUA is highlighted (cyan rectangle) and the important motifs of the secondary structure, i.e. b-strands (orange), a-helix (purple) and loops
(cyan), are labeled. The structures (a)–(c) are compared in Supplementary movies S1–S3.
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kept at 310K by applying Langevin forces with a damping
coefﬁcient of 0.1ps
 1 (44) only to the oxygen atoms of
water molecules.
Each simulated system was ﬁrst energy-minimized for
2000 steps and then heated to 310K in 4ps. After heating,
each simulated system was equilibrated for 500ps with
harmonic restraints applied to all protein and DNA
atoms under NPT ensemble conditions using
Nose ´ -Andersen Langevin piston pressure control (44,45),
allowing the systems to acquire a constant volume. With
restraints turned off each system was then subjected to 2
ns-equilibration under NVT ensemble conditions. Finally,
a 30ns [100ns in case of simulation (i)] production MD
simulation was carried out in the NVT ensemble. Table 1
lists all the simulations carried out in the present study.
Data analysis. Analysis and snapshots of the molecular
structures from MD simulations were realized with
VMD (38). To evaluate the binding strength of MBD to
the mDNA, we analyzed the contact area, s(t), between
protein and DNA through MD trajectories. s(t) is deﬁned
as
 ðtÞ¼
SprotðtÞþSDNAðtÞ SprotþDNAðtÞ
2
; ð1Þ
where Sprot(t), SDNA(t) and Sprot+DNA(t) denote the
time-dependent solvent accessible surface area (SASA)
of protein, DNA and protein–DNA complex, respectively.
The SASA values of selected atoms were calculated using
the built-in SASA function in VMD (38), which uses an
assigned radius (van der Waals radius) for each atom and
extends the radius to a user-deﬁned value (here we used
1.4 A ˚ ) to ﬁnd the points on a sphere that are exposed to
solvent. The SASA function in VMD is based on the
Shrake–Rupley algorithm (46).
To characterize the thermodynamics of arginine and
guanine pairing, we monitored the time evolution of
hydrogen bonding between arginine and guanine. A
hydrogen bond is considered formed when the dis-
tance between a hydrogen atom and an acceptor atom is
<2.5 A ˚ .
Ab initio quantum chemistry calculations
The gas-phase interaction energy of the stair motif in the
MBD1–DNA complex was determined using the
quantum-chemistry package GAMESS (47), employing
second-order Møller–Plesset perturbation theory (MP2)
(36,48–50). The electronic wave function was expanded
in a sum of Gaussian functions employing the
6-311+ +G(d, p) Pople-type basis set of triple-z accuracy
(51). This basis set, which includes polarization d and p
functions and double-diffuse functions (51), is important
for a proper MP2 estimate of the interaction energy
arising in the stair motif of the MBD–DNA interface
(36). Tests for accuracy of different basis sets and different
quantum-chemistry methods [MP2 (52), coupled-cluster
single and double excitation (CCSD) (53) and density
functional theory (DFT) (54–57)] are discussed in the
Supplementary Data.
Calculations were performed for the mCYT106 ;
ARG22 _ GUA107 and mCYT118 ; ARG44 _
GUA119 stair motifs in the MBD1–mDNA complex.
Each stair motif includes a methylated/no-methylated
cytosine, a guanine and an arginine, along with
hydrogen atoms terminating the side chains of these
residues. The mCYT-ARG-GUA stair motif contains 51
atoms; the CYT-ARG-GUA stair motif contains 48
atoms. The geometry of the stair motifs used in the
single-point energy calculations was extracted from the
structures of the MBD1–DNA complex arising in the mo-
lecular dynamic simulations. Optimizations prior to the ab
initio calculation of the MBD1–mDNA complex in water
was done starting from selected conformations from the
20–30 ns MD simulation interval, and using the conjugate
gradient energy minimization method with the
CHARMM force ﬁeld (41) in NAMD (39). Structure op-
timization is necessary for quantum-chemistry calcula-
tions, which should be performed on an equilibrated
molecular system to reveal the energy difference in the
binding energy of a MBD to methylated and
non-methylated DNA, as the difference is relatively
small. If non-equilibrium structures were used, the small
energy difference may become masked by energy contri-
butions from unfavorable orientation of interacting
residues. The optimization was carried out for 50000
steps. After 50000 steps of optimization the total energy
of the system did not change beyond 0.0001kcal/mol
( 2 10
 9 kcal/mol per atom) during one step, implying
convergence of the studied structure to a local energy
minimum.
In order to examine the inﬂuence of the methyl groups
on stair motif energetics, the methylated cytosines in the
selected snapshots from the MD simulation were
substituted by non-methylated cytosine residues and the
derived structures were then optimized using NAMD (39)
before performing quantum-chemistry single-point energy
calculations.
To characterize the MBD1–mDNA and MBD1–nDNA
binding we considered the three body interaction energies
in the mCYT ; ARG _ GUA and nCYT ; ARG _
GUA stair motifs which are deﬁned as
Ex
m ¼EðmCYT;ARG _ GUAÞ
x   EðmCYTÞ
x
  EðARGÞ
x   EðGUAÞ
x:
ð2Þ
Table 1. List of performed simulations
Index DNA Protein Mutation Time (ns)
(i) Methylated MBD1 – 100
(ii) Non-methylated MBD1 – 30
(iii) Methylated MBD1 V20A 30
(iv) Methylated MBD1 R22A 30
(v) Methylated MBD1 Y34A 30
(vi) Methylated MBD1 R44A 30
(vii) Methylated MBD1 S45A 30
(viii) Methylated MBD2 – 30
(ix) Methylated MeCP2 – 30
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n ¼EðnCYT;ARG _ GUAÞ
x   EðnCYTÞ
x
  EðARGÞ
x   EðGUAÞ
x ð3Þ
Here, the subscripts m and n denote the methylated and
the non-methylated cases of the stair motif, respectively.
The superscript x=1, 2 denotes the CYT106 ; ARG22
_ GUA107 stair motif (x=1) and the CYT118 ;
ARG44 _ GUA119 stair motif (x=2); E(CYT ; ARG
_ GUA) is the total energy of the stair motif, while
E(CYT), E(ARG) and E(GUA) are the energies of its in-
dividual components, corresponding to the energy of
cytosine, guanine and arginine, respectively.
From Equations (2) and (3) the change of the binding
energy in the MBD1–DNA stair motifs due to DNA
methylation can be calculated as
Ex ¼ Ex
m   Ex
n: ð4Þ
The ab initio quantum chemistry calculations performed
include a correction of the basis set superposition error
(BSSE) using the Boys and Bernardi function counter-
poise (FCP) method (58); such correction is crucial for
the accurate calculation of Ex
m and Ex
n in Equations (2)
and (3) (36,59).
Alchemical FEP calculations
FEP calculations (60–63) were performed to determine the
free-energy change of MBD1–DNA binding upon
cytosine methylation using NAMD. According to the
thermodynamic cycle shown in Figure 3, the net
free-energy change for the MBD–DNA ! MBD–
mDNA transformation (G) can be written
G ¼ G2   G1 ¼ Gmet complex   Gcomplex:
ð5Þ
Here, G1 was calculated by mutating non-methylated
free DNA into methylated free DNA in water and G2
was calculated by mutating the nDNA–protein complex
into mDNA–protein in water. We performed the trans-
formations in both directions and used the Bennett
acceptance-ratio (BAR) estimator (63,64) to obtain the
maximum-likelihood value of the free energy together
with the statistical error.
The FEP calculations were carried out using 25 inter-
mediate states ( =0.04), which represent a total
simulation time of 40 ns for each unidirectional simula-
tion.   is a general-extent parameter (65) introduced to
transform the system between the reference,
non-methylated state, i.e. the state with  =0, and the
perturbed, methylated state, i.e. the state with  =1.
The ParseFEP plug-in of VMD (63) was employed to de-
termine the BAR estimator alongside with its variance by
combining forward and backward transformations.
RESULTS
In the following section the interaction of methylated and
non-methylated DNA with MBD is studied in detail.
Particular attention is paid to the structural and energetic
analyses of the CYT ; ARG m GUA stair motifs at the
MBD–DNA interface. Combination of classical MD
simulations and quantum-chemistry calculations is used
to explain mDNA recognition by MBD proteins.
Stair motifs at the MBD–mDNA interface. Structures of
MBD1–mDNA, MBD2–mDNA and MeCP2–mDNA
complexes reveal that the conserved residues ARG22
and ARG44 form hydrogen bonds with guanines in the
mCpG steps (21,23,28). The NMR structure of MBD1–
mDNA shows that either ARG22 or ARG44 form a single
hydrogen bond with guanine, while the X-ray structure of
MeCP2–mDNA and the NMR structure of MBD2–
mDNA clearly show that two hydrogen bonds are
formed between each arginine and guanine. The crystal
structures showing that ARG22 and ARG44 interact
with mCpG steps in MBD1–mDNA, MBD2–mDNA
and MeCP2–mDNA complex are provided in
Supplementary Figure S1a, c and e. To investigate the
role of ARG22 and ARG44 in recognizing the mCpG
steps, we conducted a 100-ns molecular dynamics
simulation [simulation (i), see Table 1] of the NMR
structure of the human MBD1–mDNA complex (21).
Interestingly, within a very short time of simulation
( 1 ns), the side chains of ARG22 and ARG44 rotated,
forming two hydrogen bonds with GUA107 and
GUA119, respectively, as shown in Figure 4a. The
length of the four hydrogen bonds formed between
ARG22 and GUA107 as well as between ARG44 and
GUA119 is  1.7 A ˚ (see Figure 4b). The ﬂuctuation of
the hydrogen bond length is small, indicating that the
hydrogen bonding between arginine and guanine is
stable (see Figure 4b). 30-ns MD simulations were
performed for the NMR structure of chicken MBD2–
mDNA [simulation (viii), see Table 1] (23) and the
X-ray structure of human MeCP2–mDNA complexes
[simulation (ix), see Table 1] (28). In both complexes,
the four hydrogen bonds between the arginines and the
guanines, observed in the crystal structures, remained
stable through the entire MD simulations (see
Supplementary Figures S1–S3).
Protein binding often induces structural changes in the
contacted DNA (66,67). In the case of the MBD–mDNA
complex, ARG22 and ARG44 insert into the major
groove of the DNA, forming hydrogen bonds with the
guanines and shifting them into the minor groove (see
Figure 3. Thermodynamic cycle describing DNA methylation in the
DNA–MBD complex. The left vertical transition was performed for
free DNA (in the absence of the protein) in water; the right vertical
transition was performed by mutating DNA to mDNA in the hydrated,
native complex. ‘DNA+MBD’ represents the free DNA and the free
MBD, while ‘DNA:MBD’ represents the DNA–MBD complex.
Nucleic Acids Research,2012, Vol.40, No. 6 2751Supplementary Figure S4). This shift decreases the
stacking interaction between guanine and cytosine in
mCpG steps, but allows the positively charged ARG22
and ARG44 to form cation-p interactions with cytosine
bases, in addition to forming hydrogen bonds to guanines.
Figure 4c shows that the distance between the center of
mass of the arginine side chains and the center of mass of
the methyl-cytosine base is well preserved during the
100-ns simulation. Two snapshots in Figure 4a illustrate
a coupled hydrogen bonding/cation-p interaction between
the arginine and the mCpG-steps in the MBD1–mDNA
complex. The spatial conﬁgurations of mCYT106 ;
ARG22 _ GUA107 and mCYT118 ; ARG44 _
GUA119 adopt a so-called stair motif. Similar stair
motifs are formed and remain stable at the MBD2–
mDNA and MeCP2–mDNA interface, as shown in
Supplementary Figures S2–S3.
Methylation stabilizes stair motif. The results presented
above show that arginine residues recognize mCpG steps
through simultaneous cation-p and hydrogen bonding
interactions. Arginine residues are expected to interact
with CpG steps at the MBD–nDNA interface as well
(33). However, mutational studies in which mCYT106
and mCYT118 were substituted by nCYT106 and
nCYT118 (nCYT denotes non-methylated cytosine)
revealed that MBD1 does not bind to non-methylated
DNA (21), indicating that the 5-methyl groups on the
methyl-cytosines are critical for the formation of the
stair motif in MBD–mDNA binding interfaces.
The inﬂuence of methylation on the stability of the stair
motif was investigated through a 30-ns MD simulation
[simulation (ii), see Table 1] for the MBD1–nDNA
complex, where the mCYT106 and mCYT118 nucleotides
were mutated into two non-methylated cytosines. The
analysis of the MD simulation trajectories showed that
the stair motifs in the MBD1–nDNA complex arising at
mCYT106 and mCYT118 remained stable in both places
for 30 ns. However, the average root-mean-square
deviation (RMSD) of the distance between ARG22 and
nCYT106 is 1.8 A ˚ , while for ARG22 and mCYT106 it is
1.0 A ˚ ; the RMSD between ARG44 and nCYT118 is 1.5 A ˚
and for ARG22 and mCYT118 it is 0.8 A ˚ , indicating that
the interactions between ARG and mCYT are more stable
than those between ARG and nCYT (see Figure 5).
Snapshots in Figure 5 demonstrate the spatial
conﬁgurations of ARG-nCYT106, ARG-mCYT106,
ARG-nCYT118 and ARG-mCYT118. The performed
Figure 4. Stair motifs in the interface of MBD1–mDNA. (a) Orientation of stair motifs mCYT106 ; ARG22 _ GUA107 (left) and mCYT118 ;
ARG44 _ GUA119 (right) in the MBD1–mDNA complex. (b) Time evolution of hydrogen bonding between the H- and N-atoms in the ARG22-
GUA107 pair (black line), H- and O-atoms in the ARG22-GUA107 pair (red line), H- and N-atoms in the ARG44-GUA119 pair (green line), H-
and O-atoms in the ARG44-GUA119 pair (blue line). (c) Time evolution of the distance between the center of mass of mCYT106 residue in the
DNA and ARG22 residue in the MBD1 protein (blue line), and the distance between the center of mass of mCYT118 residue in the DNA and
ARG44 residue in the MBD1 protein (red line). mCYT indicates the methylated cytosine residues.
2752 Nucleic Acids Research, 2012,Vol.40, No. 6analysis of the MBD1–DNA complex suggests two
contributions to MBD–mDNA recognition as discussed
below.
The ﬁrst contribution stems from the contact area
between mDNA and the MBD, which increases upon
cytosine methylation. The contact area, s, deﬁned in
Equation (1), is the surface buried at an interface
between DNA and protein, which affects the binding
free energy (68) and, therefore, contributes to the stability
of the DNA–protein complex. In the case of the MBD–
mDNA binding, the methyl groups lead to an increase of
the contact area between cytosine and arginine in the stair
motif, as illustrated in the snapshots in Figure 5 and
Figure 6. Moreover, since several other amino acids in
the MBD have direct contact with the mCpG steps, e.g.
ASP32 and TYR34, replacing a hydrogen atom with a
methyl group likely increases the total interfacial area
between DNA and MBD. Indeed, the contact area
between mCYT106 and MBD1 is  200 A ˚ 2, the contact
area between mCYT118 and MBD1 is  150 A ˚ 2 and the
total contact area between mDNA and MBD1 is  804 A ˚ 2
(see Figure 6). After altering mCYT to nCYT, the values
of the contact area decrease signiﬁcantly: the contact area
between nCYT106 and MBD1 drops to  170 A ˚ 2, the
contact area between nCYT118 and MBD1 decreases to
 130 A ˚ 2 and the total contact area between DNA and
MBD1 decreases to  700 A ˚ 2.
The second contribution to MBD–mDNA recognition
stems from the formation of the mCYT ; ARG _ GUA
stair motif that arises twice in the MBD–mDNA interface
and is stabilized by cytosine methylation. The motifs
exhibit a favorable contact potential energy between
MBD and mDNA. In fact, the stair motif induces a
cation-p interaction between the aromatic cytosine and
the positively charged arginine, and two hydrogen bonds
between arginine and guanine. The classical force ﬁeld
used in our MD simulations does not accurately account
for polarizability and charge-transfer effects, especially
those arising through cation-p interaction (69–72). The
quantum many-body effects, i.e. when the interactions
between each monomer in the stair motif are non-
additive, are also not included in MD simulations (36).
For this reason we performed quantum chemistry
calculations of the interaction energy in the mCYT ;
ARG _ GUA and nCYT ; ARG _ GUA stair motifs
in order to determine the impact of the methyl group on
the stair motif stabilization. The interaction energy
differences E
x [see Equation (4)] between methylated
and non-methylated stair motif at x=1 (CYT106 ;
ARG22 _ GUA107) and x=2 (CYT118 ; ARG44 _
GUA119) are presented in Figure 7. The average value of
E
1 is  0.81±0.33kcal/mol; the ﬂuctuations arise
mainly due to the fact that, after optimizing the structure
of the MBD1–DNA complex in the solvent, the structures
of the stair motif in the complex are at different local
minima, with slightly different potential energies. The
average value of E
2 is  0.80±0.44kcal/mol, i.e. very
close to E
1. Thus, the total change of the interaction
Figure 5. Stabilization of the MBD1–mDNA complex due to CYT106 and CYT118 methylation. (a) Comparison of the RMSD for ARG22-
nCYT106 (blue line) and ARG22-mCYT106 (red line). (b) Comparison of the RMSD for ARG44-nCYT118 (blue line) and ARG22-mCYT118
(red line). The structure of the relevant part of the methylated and non-methylated MBD1–DNA complexes is shown on the right. The van der
Waals surface of residues is shown in wireframe representation. Two movies are provided in Supplementary Data showing the dynamics of
mCYT106 ; ARG22 _ GUA107 (Suplementary Movie S4) and CYT106 ; ARG22 _ GUA107 (Supplementary Movie S5).
Nucleic Acids Research,2012, Vol.40, No. 6 2753energy in the two stair motifs is  1.61±0.77kcal/mol.
The corresponding three-body interaction energies are
given in Supplementary Table S1.
In order to test whether the MP2 method properly
describes the interaction between CYT106 and ARG22,
two alternative quantum-chemistry methods (CCSD and
DFT) were used for the calculation of the energy
differences between the methylated and the non-
methylated states of the CYT ; ARG _ GUA stair
motif. As shown in Supplementary results (see
Supplementary Table S2 and Figure S7), the results
obtained using the CCSD method (53) are consistent
with those at the MP2 level, while the density functional
theory does not describe appropriately the long-range
dispersion interactions (73,74), i.e. a part of van der
Waals interactions. This result is expected; the discrepancy
between CCSD and DFT methods suggests that the
dispersion interaction contributes strongly to stair motif
stabilization. The three-body (mCYT ; ARG _ GUA)
and two-body (mCYT106 ; ARG22) interaction energy
differences upon methylation were also calculated using
the CHARMM force ﬁeld (see Supplementary Figures
S5 and S8). Consistent with QM calculations, the results
show a stabilization effect of cytosine methylation on the
studied system.
Free-energy contributions of DNA methylation to MBD1–
DNA complex stabilization. The protein–DNA binding
afﬁnity is affected by different interactions. In order to
account for the total effect of methylation on the stability
of the MBD–DNA complex, a thermodynamic analysis of
the changes in binding free-energy is needed. For this
purpose, FEP calculations were performed to characterize
the free-energy contribution of the methyl group to the
MBD–DNA complex. The free-energy changes for the
MBD1–DNA complex and free DNA are shown in
Supplementary Figure S6. The BAR (see ‘Methods’
section) free-energy difference for the free DNA was
determined to be G1=54.9±0.0 kcal/mol, with  0.12
kcal/mol hysteresis between forward and backward
transition; for the MBD–DNA complex, the free-energy
difference was determined to be G2=53.7±0.1kcal/
mol, with 0.2 kcal/mol hysteresis between forward and
backward transition. The hysteresis can be interpreted as
an estimate of the systematic error of the FEP calculation,
restricted to ﬁnite-length errors, i.e. not accounting for
force-ﬁeld inaccuracies or inadequate algorithms (63).
Following Equation (5), one obtains G= 1.2±0.1
kcal/mol, hence, indicating that methylation makes a
favorable contribution to the binding free energy.
Binding afﬁnity of mutated MBD for mDNA. Previous
mutagenesis studies have shown that several residues of
the MBD play key roles in binding to mDNA. Ohki et al.
(21) suggested that the recognition of mCpG steps is due
to combined hydrophobic and polar contacts made by ﬁve
residues of MBD, namely VAL20, ARG22, TYR34,
ARG44 and SER45. The hydrophobic region of each
residue forms a hydrophobic patch around the
methylation sites, while the polar moieties form
hydrogen bonds with the polar atoms of DNA.
Mutation of these residues can signiﬁcantly reduce the
binding afﬁnity for mDNA (21). Consistent with
Figure 6. Effect of CYT106 and CYT118 methylation on the MBD1–
DNA contact area. Time evolution of the surface contact area
calculated, using Equation (1), between (a) CYT106 and MBD1,
(b) CYT118 and MBD1 and (c) DNA and MBD1. Red and blue
lines correspond to the case of methylated and the non-methylated
DNA, respectively.
Figure 7. Inﬂuence of cytosine methylation on MBD1 binding energy.
The energy difference E is obtained from quantum chemistry
calculations for the two stair motifs arising in the MBD1–DNA
interface (see Figure 4). The total energy E=E
1+E
2 [see
Equation (4)] shows the three-body interaction energy difference of
the mCYT ; ARG _ GUA stair motifs on the MBD1–DNA interface
calculated for methylated (Em) and non-methylated (En) cytosine. The
blue line (squares) shows the interaction energy calculated for the
mCYT106 ; ARG22 _ GUA107 stair motif, the red line (triangles)
shows the interaction energy calculated for the mCYT118 ; ARG44 _
GUA119 stair motif, while the green line (dots) shows the combined
energy difference.
2754 Nucleic Acids Research, 2012,Vol.40, No. 6mutagenesis studies, MD simulations revealed that
mutants of MBD1 cause a decrease of the contact
interfacial mDNA binding area, reducing the mCpG-
binding afﬁnity. Figure 8a shows that the average
contact area between mDNA and wild MBD1 is 804 A ˚ 2,
while for the V20A mutant the average contact area is 752
A ˚ 2, for the R22A mutant 678 A ˚ 2, for the D32A mutant
767 A ˚ 2, for the Y34A mutant 730 A ˚ 2, for the R44A
mutant 625 A ˚ 2 and for the S45A mutant 723 A ˚ 2.
Remarkably, mutations of ARG22 and ARG44 to
alanines decrease the average contact area signiﬁcantly,
namely by 150 A ˚ 2, which again emphasizes the important
role of ARG22 and ARG44 in mCpG recognition. We
also monitored hydrogen bonding between mDNA and
MBD. Figure 8b shows the average number of interfacial
hydrogen bonds for wild-type MBD1 MBD (13 bonds on
average), V20A mutant (9 bds.), R22A mutant (9 bds.),
D32A mutant (10 bds.), Y34A mutant (10 bds.), R44A
mutant (9 bds.) and S45A (10 bds.). MBD mutation is
found to reduce the number of hydrogen bonds between
MBD1 and mDNA. The R22A and R44A mutants are
seen to have the largest impact on reducing hydrogen
bonding with mDNA. The last column in the histogram
in Figure 8b depicts the average number of hydrogen
bonds in non-methylated DNA bound to wild-type
MBD1. In the case of the MBD–DNA complex,
although methyl groups are not involved in any
hydrogen bonding, removing two methyl groups leads to
a decrease of the MBD–DNA contact area (Figure 6),
reducing the number of interfacial hydrogen bonds. We
note that prior studies have also shown that mutation
causes structural rearrangement at the protein–DNA
interface, changing DNA-binding afﬁnity (75,76).
DISCUSSION
In the present study, we investigated the role of the stair
motif that combines arginine–guanine hydrogen bonding
and arginine–cytosine cation-p stacking in the recognition
of mCpG steps by MBD. Sequence alignment of human
and mouse MBD family proteins shows that two arginine
amino acids (ARG22 and ARG44) involved in stair motifs
formation are strictly conserved, suggesting that these
arginines play a crucial role in MBD–mDNA binding.
Indeed, MD simulations and quantum-chemistry
calculations, the latter restricted to the stair motif
formed by arginine and mCpG steps at mCYT106 and
mCYT118, show that methylated cytosine renders the
stair motif more stable than does non-methylated
cytosine. FEP calculations take into account the energy
costs of methylation-induced deformations at the MBD–
DNA binding interface, e.g. the displacement of mCpG
step guanine to the minor groove, and the potential energy
change in the stair motif, e.g. the change in cation-p
interaction energy between arginine and cytosine upon
methylation, quantifying the overall effect of DNA
methylation on MBD–mDNA complex stability.
Our results quantiﬁed also that methylation increases
the buried hydrophobic surface between MBD and
DNA by  100 A ˚ 2. Previous theoretical and experimental
studies suggested that decreasing the hydrophobic surface
by 1 A ˚ 2 reduces the interface stabilization free energy by
15±1.2cal/mol (68,77). Therefore, in the case of the
MBD–mDNA complex, methylation contributes about
100 15 cal/mol = 1.5kcal/mol to the stability of
MBD–mDNA binding, which is close to the value
( 1.2±0.1 kcal/mol) obtained through FEP calculations.
Figure 8. Mutation effects on characteristics of the MBD1–DNA interface. (a) Comparison of the contact area between DNA and mutants of
MBD1. The dashed line shows the average contact area for wild-type MBD1–mDNA. (b) Comparison of the number of hydrogen bonds between
DNA and mutants of MBD1. The dashed line shows the average number of interfacial hydrogen bonds for wild-type MBD1–mDNA.
Nucleic Acids Research,2012, Vol.40, No. 6 2755The recognition of the 50-pyrimidine-purine-30 step via
stair motifs through arginine residues has been observed in
many protein–DNA complexes (33,36). An example is the
sporulation-speciﬁc transcription factor Ndt80.
Lamoureux et al. (32–34) reported that two 50-TpG-30
steps are recognized by Ndt80 via two arginines; the
non-polar region of the arginines forms a hydrophobic
half-pocket for the methyl group of a thymine, while the
polar region contacts the guanine bases. Interestingly, the
methyl group in the thymine was found to be crucial for
the cation-p interaction between the thymine and the
arginine, as substitution of the thymine with uracil,
which lacks a methyl group, effectively results in a
signiﬁcant loss of Ndt80 binding afﬁnity (32–34).
Similarly, the 5-methyl group on methyl-cytosine is
crucial for MBD proteins to recognize mCpG steps.
However, previous studies did not address how the
methyl groups in DNA lead to such a signiﬁcant protein
binding speciﬁcity, leaving a gap for speculation. Filling
this gap, we have demonstrated in the present study that
the effects of the 5-methyl group arise from a change of
binding afﬁnity due to an increased contact area and
cation-p interaction.
Binding of a protein to a particular site in DNA
involves guidance through protein tertiary structure,
DNA local conformation and DNA sequence (78,79). It
is worth noting that the binding afﬁnities of MBD
proteins for mDNA are sequence-dependent as they
target different methylated promoters (17,80). For
example, MeCP2 binds more efﬁciently to mCpG steps
with adjacent A/T bases (81), while MBD1 strongly
prefers an mCpG step in the context of TmCGCA and
TGmCGCA in vitro and in vivo (82). A recent NMR
study of MBD2 bound to mDNA revealed that MBD2
has high afﬁnity for an mCGG sequence (23). Earlier
studies suggested that the binding afﬁnities of MBD
proteins for different mDNA sequences can be attributed
to speciﬁc residues within the MBD. Future investigations
on speciﬁc binding properties of MBD proteins at atomic
resolution are needed to explain the observed sequence
speciﬁcities.
In this article we have addressed an important question
in epigenetics, namely how MBD proteins are capable of
recognizing methylated DNA. Although we answered
some questions, others remain open, such as those
regarding the mDNA interaction with other mDNA-
binding proteins, e.g. Kaiso protein, the inﬂuence of the
solvent on the MBD–mDNA interaction, temperature and
pressure effects on mDNA binding. Epigenetics is still a
long way from a thorough understanding of how
methylated DNA conducts its functions in the cell and
further studies should be initiated to learn more about
the crucial, although subtle mDNA recognition process.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–2, Supplementary Figures 1–8,
Supplementary Movies 1–5 and Supplementary Results.
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